During the 1960s, hospital admission rates in England and Wales for childhood asthma steadily increased. This trend continued into the 1980s and began a steady decline in the 1990s, with no apparent explanation for this trend ([@b27-ehp0115-001691]). By 2000, annual admissions for asthma in England and Wales were 48 and 16 per 10,000 in children younger than 5 and those 5--14 years, respectively ([@b22-ehp0115-001691]). In 2004, asthma caused 1,266 deaths in England and Wales, 38 of which were children younger than 14 years, accounting for 2.9% of all deaths of 1- to 14-year-olds ([@b22-ehp0115-001691]). In the United States, the prevalence of self-reported asthma reached a peak of 60.5 per 1,000 population in children 0--4 years of age and 82.5 in children 5--14 years of age in 1995 and has since declined ([@b18-ehp0115-001691]).

A known risk factor for the development of atopic asthma is exposure and sensitisation to the house dust mite *Dermatophagoides pteronyssinus*. A meta-analysis of measures to reduce house dust mite exposure concluded there was no evidence to suggest implementing avoidance measures ([@b13-ehp0115-001691]). However, the review did not include any prospective studies examining potential avoidance of atopic disease development. If the etiology of asthma and the role of household interventions in mitigating the disease can be more fully understood, there is an increased likelihood that asthma can be treated more appropriately and perhaps prevented.

Our primary objective was to assess whether any household intervention aimed at ameliorating exposure to house dust mite could reduce the incidence of asthma in high-risk children or reduce the severity of asthma in individuals already diagnosed with the disease.

Data Sources
============

Potential studies on household intervention and asthma were identified from a series of electronic searches. Databases searched were the Cochrane Central Register of Controlled Trials (CENTRAL; <http://www.mrw.interscience.wiley.com/cochrane/cochrane_clcentral_articles_fs.html>), MEDLINE (<http://gateway.ovid.com/>), and EMBASE (<http://www.embase.com/>). Searches were conducted in week 2 of 2007, and no date or language restriction was placed on the literature search. The databases were searched with the following criteria: "hypersensitivity" \[MeSH term\] OR "hypersensitivity" \[text word\] OR "asthma" \[MeSH term\] OR "asthma" \[text word\] OR "eczema" \[MeSH term\] OR "eczema" \[text word\] OR "dermatitis atopic" \[MeSH term\] OR "dermatitis atopic" \[text word\] OR "allergy" \[MeSH term\] OR "allergy" \[text word\] AND "household" \[MeSH term\] OR "hygiene" \[text word\] OR "hygiene" \[MeSH term\] OR "hygiene" \[text word\] OR "animal domestic" \[MeSH term\] OR "domestic animal" \[text word\] OR "pets" \[text word\] OR "dust" AND "randomized controlled trials" \[MeSH term\] OR "randomized controlled trial" \[text word\] OR "randomized controlled trial" \[text word\] OR "RCT" \[text word\].

In addition, when close to completion, we performed a further search of articles searching only for recent articles and using the terms "dust" and "asthma" for 2006 onward. Also, the Institute of Scientific Information database of global conference proceedings (<http://portal.isiknowledge.com/>) was searched for abstracts of relevant presentations at scientific conferences for 2002 and later that had not yet been published as full articles.

Abstracts for all the publications identified by the search were reviewed and assessed for suitability for inclusion by two authors of the present article. Where disagreement occurred, a third assessor contributed to the final decision. Full copies of all suitable studies were obtained, and a further decision was made as to whether they fulfilled the search criteria. During the entire selection process, none of the authors were blinded to the source of the publication, its authors, or any other detail.

Data Extraction
===============

Types of studies
----------------

All randomized trials that compared any household intervention to a control group with placebo (where practical) or no intervention were considered for this review.

Types of participants
---------------------

As atopic disease affects adults and children, no restriction was based on age, hence studies that had their own age restriction were considered. It was anticipated that there would be a mixture of studies recruiting in the antenatal period prospectively examining the development of atopic disease and those that recruited known atopic individuals.

Those studies recruiting subjects known to be atopic needed to have either a clinical diagnosis of asthma or positive skin prick test to a known trigger allergen. Prospective studies with antenatal recruitment had a first-degree relative with a clinical diagnosis of atopic disease or atopic disease confirmed on skin-prick testing. Studies would still be considered if they compared these individuals with lower-risk individuals, as long as there was a direct comparison between two groups of high-risk individuals receiving or not receiving a household intervention.

Types of intervention
---------------------

Inevitably, there would be a wide range of household interventions. Those considered for review were the following:

-   Provision of allergen-impermeable bedding compared with no change in care or with placebo.

-   Provision of household cleaning product or equipment (for example, high-efficiency vacuum cleaners) compared with no change or with the provision of placebo/alternative products.

-   Education programs about allergen reduction measures compared with no additional educational input.

-   Changes to home environment (for example, mold reduction and repairs to heating systems) compared with no change in home environment or with education only with no physical help.

Types of outcome measures
-------------------------

Any outcome measure referring to the development, exacerbation, or severity of atopy was considered. We anticipated that many studies examining allergen reduction would measure allergen levels as a primary outcome. As this was not the aim of the present review, such studies would be included only if they also provided a measurement of atopic disease indicators. Types of outcome measures indicating the development of atopy were as follows: *a*) presence of wheeze (noted by parent or general practioner); *b*) diagnosis of asthma; *c*) prescribed asthma medication; and *d*) positive skin test to an aeroallergen.

Below are the types of outcome measures indicating the severity of atopy in studies in which participants were known to be atopic: *a*) severity of eczema; number of acute hospital/ clinic visits for asthma; *b*) combined asthma outcome \[a measure based on treatment requirement and bronchial hyperreactivity to histamine used by [@b12-ehp0115-001691]\]; *c*) lung function; *d*) peak flow; and *e*) diary days with chest tightness.

Analysis
--------

We methodologically assessed the studies meeting the inclusion criteria using a validated five-point scoring system ([@b14-ehp0115-001691]). This tool assesses quality of randomized controlled trials on the basis of the reported quality of randomization, blinding, and adequate descriptions of subject withdrawals and dropouts. The score is calculated according to whether the study is randomized and double blinded. Additional points are given based on the description of withdrawals and adequacy of description of the randomization and blindness. Data were extracted using a standard form adapted from a sample form provided by the [@b3-ehp0115-001691]. The main data extracted were duration of study, study size, nature of intervention, and outcome measures. The data were then entered into a Microsoft Excel (Microsoft Corp., Redmond, WA, USA) spreadsheet for analysis .

Meta-analysis was done using StatsDirect ([@b26-ehp0115-001691]). For continuous outcomes such as peak flow or days of symptoms, an effects-size meta-analysis was performed. For dichotomous outcomes relative risk meta-analysis is reported. Given the diversity of interventions included, random-effects models were used. In addition, data were tested for bias and study heterogeneity.

Data Synthesis
==============

Description of studies
----------------------

The initial electronic search yielded 248 references. Duplicates (studies found by more than one database) were excluded and the remaining abstracts screened by C.R. and A.S. After the screening, 33 references were selected to be more thoroughly examined for potential inclusion. Eleven of these met the inclusion criteria for the present review. Three additional recent articles were identified using the search, bringing the total to 14 to meet the inclusion criteria.

The characteristics of the studies meeting the criteria for inclusion, including types of participants, duration of the study, and a summary of the intervention used are presented in [Table 1](#t1-ehp0115-001691){ref-type="table"}.

One meeting abstract was identified that investigated the impact on symptoms of asthma, but this was a small study of only 44 children with asthma and no controls; thus, this was not analyzed further ([@b4-ehp0115-001691]).

Methodological quality
----------------------

The quality of reporting in the studies included was variable, with included studies all achieving either 2 or 3 with a mean Jadad score of 2.4. In some cases the study design was prohibitive of a blinding process, thus preventing the studies from reaching a score \> 3 based on the Jadad criteria.

The population sizes in the studies identified ranged from 30 to 937 and the duration of follow-up ranged from 6 months to 7 years. Most studies did not provide placebo interventions for the control group and left the group with no change in their care. Three studies used placebo, two provided a nominal part of the intervention and one provided the same information and equipment after completion of the study period.

Separate analyses were performed of those studies measuring prevention and those assessing improvement.

Prevention of asthma
--------------------

Eight studies considered interventions to prevent asthma ([@b1-ehp0115-001691]; [@b2-ehp0115-001691]; [@b8-ehp0115-001691], [@b9-ehp0115-001691]; [@b10-ehp0115-001691]; [@b11-ehp0115-001691]; [@b19-ehp0115-001691]; [@b23-ehp0115-001691]). Three articles represented repeat analyses of the same cohort; thus, only the most recent report was included in the analysis ([@b2-ehp0115-001691]; [@b8-ehp0115-001691], [@b9-ehp0115-001691]).

Five of the studies had comparable interventions, providing education about allergen exposure reduction as well as allergen reduction equipment ([@b1-ehp0115-001691]; [@b9-ehp0115-001691]; [@b10-ehp0115-001691]; [@b11-ehp0115-001691]; [@b19-ehp0115-001691]). The sixth did not implement any physical changes but provided a comprehensive education program on how to reduce newborns' exposure to allergens ([@b23-ehp0115-001691]).

All six studies were analyzed for two outcome measures: physician-diagnosed asthma and parent-reported wheeze. From the data available in this outcome measure, a relative risk meta-analysis was performed. The forest plots are shown in [Figures 1](#f1-ehp0115-001691){ref-type="fig"} and [2](#f2-ehp0115-001691){ref-type="fig"}. All five studies that reported on physician-diagnosed asthma demonstrated a reduction in diagnosed asthma in the intervention arm by the end of the study period, although in only one was this statistically significant. Nevertheless, the pooled estimate showed a significant reduction \[relative risk (RR) = 0.79; 95% confidence interval (CI) 0.66--0.94; *p* = 0.0093, fixed-effects model). There was no evidence of bias (0.091), and Cochran's Q was not statistically significant (*p* = 0.626), supporting the use of the fixed-effects model.

For the five studies that reported on parent-reported wheeze, only one study showed a significant reduction in the intervention arm and two showed an actual increase. The combined effect of the interventions did not show a significant impact on parent-reported wheeze (RR = 0.95; 95% CI 0.78--1.15; *p* = 0.616). However, both bias (*p* = 0.005) and Cochran's Q (*p* = 005) were statistically significant, indicating possible bias in the results and heterogeneity in the study outcomes.

Improvement in already-diagnosed asthma
---------------------------------------

Six of the identified studies were concerned with estimating the impact of house dust reduction on the severity of asthma ([@b7-ehp0115-001691]; [@b12-ehp0115-001691]; [@b16-ehp0115-001691]; [@b17-ehp0115-001691]; [@b21-ehp0115-001691]; [@b28-ehp0115-001691]). Many different outcome measures were used in these studies, and often the analyses presented for these outcome measures differed. Two outcome measures were used for meta-analysis. Three studies reported some form of a result of lung function such as FEV~1~ (forced expiratory volume in 1 sec) or peak flow ([@b12-ehp0115-001691]; [@b17-ehp0115-001691]; [@b21-ehp0115-001691]). For these three studies we conducted an effects-size meta-analysis ([Figure 3](#f3-ehp0115-001691){ref-type="fig"}). The pooled estimates of effects size did not show any significant impact of the intervention (−0.084; 95% CI, 0.452--0.284).

There was sufficient information on only two studies to perform a meta-analysis for days with symptoms ([Figure 4](#f4-ehp0115-001691){ref-type="fig"}) ([@b17-ehp0115-001691]; [@b21-ehp0115-001691]). The meta-analysis showed a significant reduction in days ill in the intervention group (−0.361; 95% CI, −0.590 to −0.131).

Several studies reported outcome measures for unplanned hospital or clinic visits; unfortunately the studies did not analyze the data similarly nor did they present their results in a form sufficient to allow a meta-analysis. However, one study worth mentioning used control, placebo, and intervention arms ([@b7-ehp0115-001691]). The study identified a significant decrease in clinic attendances in the intervention and placebo arms but not in the control arms, suggesting that there is a strong placebo effect on subjective measures of asthma severity.

Conclusions
===========

One major difficulty in conducting this review and meta-analysis was the wide range of different outcome measures used and the ways in which such measures were analyzed and presented. This made extraction of data particularly difficult, especially for those studies investigating dust reduction interventions as a means of reducing the severity of asthma. It is necessary that there be standardization in reporting the results of studies of interventions aimed at reducing the severity of symptoms of asthma. A further issue was the relatively low Jadad score of only 2.4, which reflects the lack of blinding in almost all studies.

The results of the present meta-analysis suggest a significant reduction in physician-diagnosed asthma as a result of interventions to reduce exposure to house dust (RR = 0.74; 95% CI, 0.58--0.95). However, there was no significant effect on parent-reported wheeze (RR = 0.95; 95% CI, 0.78--1.15). This may suggest that reduced exposure to house dust prevents the more severe form of asthma but not the more common and milder forms. This is consistent with the observation that the majority of physician-diagnosed asthma cases in children are atopic, whereas many cases of parent-reported wheeze are often not atopic ([@b15-ehp0115-001691]; [@b20-ehp0115-001691]). Indeed parents frequently err in reporting the presence of wheeze, both erroneously reporting its presence when it is not there and not recognizing wheeze when it is there ([@b6-ehp0115-001691]; [@b5-ehp0115-001691]). Nevertheless, a 26% reduction in physician-diagnosed asthma would be a worthwhile benefit.

The results of the analyses on disease severity reduction were conflicting. The results of lung function did not show improvement (−0.084; 95% CI, −0.452 to 0.284), whereas the number of days ill, a more subjective estimate of severity, was reduced (−0.361; 95% CI, −0.590 to −0.131). Together, the findings of this review and the results of the meta-analysis give an uncertain and mixed estimate of the value of interventions aimed at reducing house dust on severity of asthma. The finding of a reduction in disease severity as measured by unplanned hospital and clinic attendances in both intervention and placebo arms in one study raises concerns that much of the impact of house dust reduction interventions may have a psychological rather than a direct effect ([@b7-ehp0115-001691]). This is particularly the case given the lack of blinding in most studies.

A further explanation for the mixed results may be that the efficiency of the interventions at reducing exposure to antigens from house dust mites varied among studies. There is evidence from some studies that dust reduction measures may not be particularly effective ([@b7-ehp0115-001691]), particularly for children living in poorer areas ([@b7-ehp0115-001691]). However, [@b24-ehp0115-001691] assessed compliance with dust reduction procedures and found good compliance with antimite encasing advice but not with more demanding actions such as the use of smooth floor coverings in living room and nursery.

In conclusion, the evidence in favor of interventions aimed at reducing exposure to house dust for the prevention of physician-diagnosed asthma in high-risk children is strong. In this regard we consider the evidence to be stronger than the conclusions of other reviews ([@b25-ehp0115-001691]). However, the impact of interventions appears not to affect parent-reported wheeze.

The evidence for house dust reduction in controlling the symptoms of asthma is currently weak, and it is not yet possible to advise on the general feasibility of this strategy in asthmatic children. One problem in determining the value of this intervention was the different outcome measure used and the way results were presented, which prevented a formal meta-analysis. Agreement is needed on appropriate standards for the conduct and analysis of future trials of environmental interventions to control the clinical severity of asthma.

C[orrection]{.smallcaps}
========================

The last name of the first author has been changed from Russell in the original manuscript published online to Macdonald in the final version.
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###### 

Randomized control studies of house dust reduction interventions on the prevention or control of asthma.[a](#tfn2-ehp0115-001691){ref-type="table-fn"}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference               Inclusion criteria                                                                                                                                                                       Duration of study   Control no.   Intervention no.   Control group intervention                                                                                         Intervention group intervention                                                                                                                             Measured prevention or improvement   Jadad score
  ----------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------- ------------- ------------------ ------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------ -------------
  [@b7-ehp0115-001691]    Present on a database as being treated for asthma                                                                                                                                        12 months           35            34                 No intervention                                                                                                    Placebo---allergen-permeable mattress and pillow covers, ineffective roach traps, no instructions                                                           Improvement                          2

                                                                                                                                                                                                                                                     35                                                                                                                                    Allergen-impermeable mattress and pillow covers, roach bait, laundry instructions, and instructions about cleaning to control dust mites                                                         

  [@b11-ehp0115-001691]   Pregnancies with either: *a*) both parents atopic, positive to skin-prick test (high risk) and pets; *c*) both parents skin-prick test negative; no family history of atopy (low risk)   12 months           146           145                No intervention                                                                                                    Allergen-impermeable bedding covers fitted to parental bed, laundry instructions, and high-filtration vacuum cleaner, damp dusting.                         Prevention                           2

                                                                                                                                                                                                                                                     161\                                                                                                                                  Vinyl cushion flooring fitted in child's bedroom, custom-made crib and cot mattresses, hot-washable soft toy, washing instructions                                                               
                                                                                                                                                                                                                                                     168                                                                                                                                                                                                                                                                                                                                    

  [@b12-ehp0115-001691]   Age between 18--65 years with a diagnosis of asthma and living with cat or dog                                                                                                           12 months           15            15                 HEPA vacuum cleaners alone, vacuuming minutes 2× per week                                                          Honeywell Envirocare HEPA cleaners in living room and bedroom and Dyson HEPA vacuum cleaners vacuuming minutes 2× per week                                  Improvement                          2

  [@b17-ehp0115-001691]   Age 18--54 years with asthma diagnosis, taking inhaled steroids, sensitive to house dust mite                                                                                            12 months           25            30                 Sham allergen- proof bed covers                                                                                    Allergen-proof bed covers                                                                                                                                   Improvement                          2

  [@b21-ehp0115-001691]   Age 5--11 years with an asthma diagnosis, asthma-related hospital admission and positive skin-prick test                                                                                 12 months           468           469                No intervention                                                                                                    Providing child's caretaker with knowledge, skills, motivation, equipment to perform environmental remediation with 5--7 home visits                        Improvement                          3

  [@b23-ehp0115-001691]   Asthma in at least mother, father, or siblings of unborn child                                                                                                                           2 years             234           242                No intervention                                                                                                    Instruction from nurses on reducing mite allergens, pet allergens, food allergens, etc.                                                                     Prevention                           3

  [@b16-ehp0115-001691]   Age 2--17 years with symptomatic asthma for at least 3 months and hospital visit with asthma in past year                                                                                12 months           33            29                 Information given improving home indoor air quality                                                                Home remediation performed 4--5 months after study began, including cleaning, repairs, air conditioning, etc.                                               Improvement                          3

  [@b8-ehp0115-001691]    High risk for atopy---at least 1 first-degree relative with asthma or 2 second-degree with other allergic diseases identified in third trimester                                         12 months           267           278                No intervention                                                                                                    Mattress assessment, laundry instructions, benzyl benzoate application to carpets and furniture, counseled about pets, smoking cessation                    Prevention                           2

  [@b2-ehp0115-001691]    High risk for atopy---at least 1 first-degree relative with asthma or 2 second-degree with other allergic diseases identified in third trimester                                         2 years             267           278                No intervention                                                                                                    Mattress assessment, laundry instructions, benzyl benzoate application to carpets and furniture, counseled about pets, smoking cessation                    Prevention                           2

  [@b9-ehp0115-001691]    High risk for atopy---at least 1 first-degree relative with asthma or 2 second-degree with other allergic diseases identified in third trimester                                         7 years             266           279                No intervention                                                                                                    Mattress assessment, laundry instructions, benzyl benzoate application to carpets and furniture, counseled about pets, smoking cessation                    Prevention                           2

  [@b28-ehp0115-001691]   English-speaking 5- to 12-year olds with asthma exacerbation presenting to ED living within the "Atlanta Empowerment Zone" (high level of poverty)                                       12 months           77            84                 Same as intervention group, after the study period                                                                 Information and equipment to reduce allergen exposure: mattress encasing, laundry instructions, hydramethylnon gel, smoking advice, professional cleaning   Improvement                          3

  [@b19-ehp0115-001691]   Prenatally identified high-risk individuals with at least 1 parent or sibling who had asthma or wheezing                                                                                 5 years             308           308                Advice about allergen reduction. Provided poly- unsaturated oils and spreads and capsules low in ω-3 fatty acids   Impermeable bedding covering, laundry instruction, advice. Provided canola-based oils and spreads and capsules containing ω-3 fatty acids                   Prevention                           2

  [@b1-ehp0115-001691]    Prenatally identified high-risk individuals (at least 2 family members with allergic disease)                                                                                            8 years             62            58                 No intervention                                                                                                    Elimination of dairy, fish, wheat, nuts, soya from diet, impermeable bedding covers, carpet, and upholstery treatment                                       Prevention                           2

  [@b10-ehp0115-001691]   Prenatally identified high risk individuals (allergic mother)                                                                                                                            4 years             394           416                Placebo bedding covers                                                                                             Allergen-impermeable covers                                                                                                                                 Prevention                           2

                                                                                                                                                                                                                                       472                              No intervention                                                                                                                                                                                                                                                                                                     
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: ED, emergency department; HEPA, high-efficiency particulate air.

Articles by [@b8-ehp0115-001691], [@b9-ehp0115-001691] and [@b2-ehp0115-001691], were analyses of the same cohort. Only the most recent articles were included in analyses.
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